← Back to Blog
BLOG - STRATEGY - ACCOUNT STRUCTURE

Peptide Brand Google Ads Account Structure Across Multiple Compounds

Selling more than one compound changes how a peptide brand's Google Ads account should be structured. Here's the campaign architecture that limits blast radius.

Blog post featured image

The single biggest structural mistake we see in multi-compound peptide brand accounts is mixing every product into shared campaigns and ad groups. It's efficient to manage, but it means a policy flag on one compound's ad copy or landing page can trigger a review that touches your entire account, not just the flagged product. Compound-level segmentation is the fix, and it's worth building in from the start rather than retrofitting after a suspension.

Why Shared Campaigns Increase Risk

Google's review systems don't always evaluate policy violations at the individual ad level in isolation, particularly for repeat or pattern-based flags. An account with a history of violations tied to one compound can see stricter, faster review applied to unrelated campaigns in the same account. Segmenting by compound limits how far a single flag's consequences spread.

Recommended Account Structure

LevelStructure
CampaignOne campaign per compound or tightly related compound family, not one campaign for the whole catalog
Ad groupSegmented by intent within each compound, e.g. informational vs. purchase-intent keywords
Landing pagesCompound-specific pages rather than a single catalog page serving all ads
Negative keywordsShared list across the account for universally excluded terms, plus compound-specific exclusions per campaign

Naming Conventions That Make Audits Faster

Consistent naming, compound name, campaign type, and date launched, makes it dramatically faster to identify which specific campaign triggered a review when a flag does happen, and to isolate it without needing to pause unrelated campaigns while you investigate.

Budget Allocation Without Cross-Contamination

  • Set budgets at the campaign level per compound rather than one shared daily budget across the account, so scaling one compound doesn't require touching settings on others
  • Track conversion performance per compound separately, both for optimization and so you can see clearly if a specific product line is driving disproportionate policy friction
  • When testing a new compound, launch it as its own isolated campaign with a small budget rather than folding it into an existing, already-approved campaign

What This Looks Like When It Works

This same segmented approach, isolating campaigns by product line so a single compliance issue never cascades account-wide, is part of how we scaled a multi-product peptide brand from $8K to $148K/month at 4.6x ROAS. See the full case study.

Reviewing Account Structure Before You Add a New Compound?

We'll map out the campaign architecture for your specific product catalog before you launch, so growth doesn't come with shared-account risk.

Book a free 30-minute audit →

Or email directly: sveta@oney.studio

Oney Studio is a specialist Google Ads agency for peptide and research chemical brands. We build compliance-first account architecture that scales, from cold start to six-figure monthly revenue, without account-level policy flags.

Ready to Scale Your Peptide Brand?

Get a free 30-minute audit of your Google Ads or Meta Ads account. We’ll review compliance, structure, and growth opportunities — no strings attached.

Book a Free Audit